RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
BioSig Technologies Stock

BioSig Technologies ROCE 2024

BioSig Technologies ROCE

9.79

Ticker

BSGM

ISIN

US09073N2018

WKN

A2N5TW

In 2024, BioSig Technologies's return on capital employed (ROCE) was 9.79, a -115.01% increase from the -65.23 ROCE in the previous year.

BioSig Technologies Aktienanalyse

What does BioSig Technologies do?

Biosig Technologies Inc is a medical technology company based in New York, specializing in the development of advanced electrophysiological (EP) instruments and accessories for use in hospitals and clinics. The company was founded in 2009 and successfully went public in June 2018. The main task of Biosig Technologies is to provide doctors and medical professionals with helpful instruments that simplify the difficult work of EP tests and ablations. The development of EP instruments typically requires high specialization, as knowledge of both electrophysiology and engineering is required. However, Biosig has already gained a high level of expertise in this field and has established itself as a leading company in the industry. Biosig Technologies' business model is based on selling EP instruments and accessories to hospitals and clinics in the US and international markets. The products include the "PURE EP System," an electrophysiological signal processing and recording system specifically designed for use in EP tests and ablations. The "PURE EP System" allows doctors to obtain accurate information about the electrical activity of the heart in order to improve the diagnosis and treatment of cardiac arrhythmias. The "PURE EP System" has proven its excellence in practice and is successfully used by many clinics and hospitals in the US. The system offers higher sensitivity and accuracy than conventional electrophysiological instruments, enabling better differentiation and representation of signals originating from different heart tissues. This allows doctors to make more accurate diagnoses and develop more targeted treatment strategies. Biosig Technologies offers a wide range of products and services tailored to the needs of customers in various areas of healthcare. The company also provides excellent customer support and training to ensure that users properly utilize the instruments and maximize their benefits. In addition to the EP field, the company is also exploring the use of the technology in other areas of medicine. Biosig Technologies actively works on the development of instruments to improve respiratory monitoring and facilitate the use of robots in surgery. The company plans to bring more instruments and accessories to the market in the future to expand its portfolio and meet additional customer needs. Biosig Technologies is a dynamic company with a high degree of innovation and a strong focus on the needs of doctors and medical professionals. The company aims to improve healthcare by providing advanced instruments and accessories, making a positive contribution to society. BioSig Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling BioSig Technologies's Return on Capital Employed (ROCE)

BioSig Technologies's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing BioSig Technologies's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

BioSig Technologies's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in BioSig Technologies’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about BioSig Technologies stock

What is the ROCE (Return on Capital Employed) of BioSig Technologies this year?

The ROCE of BioSig Technologies is 9.79 undefined this year.

How has the ROCE (Return on Capital Employed) of BioSig Technologies developed compared to the previous year?

The ROCE of BioSig Technologies has increased by -115.01% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of BioSig Technologies?

A high Return on Capital Employed (ROCE) indicates that BioSig Technologies has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of BioSig Technologies?

A low ROCE (Return on Capital Employed) can indicate that BioSig Technologies has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from BioSig Technologies impact the company?

An increase in the ROCE of BioSig Technologies can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of BioSig Technologies affect the company?

A decrease in ROCE of BioSig Technologies can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of BioSig Technologies?

Some factors that can affect BioSig Technologies's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of BioSig Technologies so important for investors?

The ROCE of BioSig Technologies is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can BioSig Technologies take to improve the ROCE?

To improve the ROCE, BioSig Technologies can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does BioSig Technologies pay?

Over the past 12 months, BioSig Technologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, BioSig Technologies is expected to pay a dividend of 0 USD.

What is the dividend yield of BioSig Technologies?

The current dividend yield of BioSig Technologies is .

When does BioSig Technologies pay dividends?

BioSig Technologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of BioSig Technologies?

BioSig Technologies paid dividends every year for the past 0 years.

What is the dividend of BioSig Technologies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is BioSig Technologies located?

BioSig Technologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von BioSig Technologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of BioSig Technologies from 9/20/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/20/2024.

When did BioSig Technologies pay the last dividend?

The last dividend was paid out on 9/20/2024.

What was the dividend of BioSig Technologies in the year 2023?

In the year 2023, BioSig Technologies distributed 0 USD as dividends.

In which currency does BioSig Technologies pay out the dividend?

The dividends of BioSig Technologies are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von BioSig Technologies

Our stock analysis for BioSig Technologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BioSig Technologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.